Suppresionof IL-34 drastically reduces tumor chemoresistance (IMAGE)

Hokkaido University

Suppresionof IL-34 drastically reduces tumor chemoresistance

Caption

Growth of TNBC tumors without any treatment (blue line); it is unaffected by paclitaxel alone (green line) and dramatically suppressed by a combination of paclitaxel and anti-IL-34 antibody (αIL-34; red line) (modified from Nabeel Kajihara, et al. Cancer Immunology, Immunotherapy. September 14, 2022).

Credit

Nabeel Kajihara, et al. Cancer Immunology, Immunotherapy. September 14, 2022

Usage Restrictions

This image is copyrighted but may be used to report on this press release if credited as instructed.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.